A Swiss passenger WHO disembarked the MV Hondius has tested positive for Andes virus, lifting the cluster to 8 cases and 3 deaths across 23 nationalities. Andes is the only hantavirus with confirmed person-to-person spread in close-contact settings, which changes what European health agencies must monitor next.
7MAY
Hantavirus comes ashore; H5N1 won't quit
2 min read
15:24UTC
An Andes-strain hantavirus case has now been confirmed in a Swiss passenger from the MV Hondius cluster, the only hantavirus capable of person-to-person spread. H5N1 has resurfaced in Idaho dairy cattle, and a new Emory study finds the virus in milking-parlour air. On the defensive side, Africa CDC and the EU launched ARILAC on 6 May to build AMR laboratory capacity across eight African states, and CEPI announced the first Phase 3 trial of an mRNA H5N1 vaccine candidate on 22 April.
Key takeaway
Institutional surveillance is outrunning operational response across every thread this week.
This briefing mapped
Andes hantavirus confirmed in Swiss returnee
A Swiss disembarkee from the MV Hondius has tested positive for Andes virus, the only hantavirus with documented person-to-person transmission, raising the cluster to 8 cases and 3 deaths.
Sources profile:This story draws on neutral-leaning sources
Emory aerosol study reframes dairy PPE
An Emory-led PLOS Biology study sampling 14 California dairy farms detected H5N1 in milking-parlour aerosols, in farm wastewater and in the exhaled breath of cows, with shedding into milk tanks before any clinical signs.
Sources profile:This story draws on neutral-leaning sources
An Emory University study published in PLOS Biology found H5N1 in submicron aerosol particles in milking-parlour air across 14 California dairy farms, in wastewater, and in cows' exhaled breath before any clinical signs appeared. The CDC and USDA have not updated dairy-worker guidance to address the aerosol route, meaning current protective equipment is calibrated to the wrong transmission pathway.
PAHO flagged Southern Cone hantavirus in December
PAHO issued a formal Epidemiological Alert on 19 December 2025 warning that hantavirus cases had risen across the Southern Cone, with Argentina running at roughly twice its prior-year baseline.
Sources profile:This story draws on neutral-leaning sources
PAHO issued a formal hantavirus alert on 19 December 2025, flagging elevated Southern Cone caseloads and rising lethality, five months before the MV Hondius cluster sailed from Ushuaia. Antarctic-cruise operators have no formal obligation to subscribe to PAHO epidemiological alerts, and none appear to have acted on the December warning.
Sources:Pan American Health Organization
Idaho dairy H5N1 breaks five-month US lull
Idaho dairy herds confirmed H5N1 in May, the first US dairy detections since Wisconsin in December, ending a quiet that had begun to read as containment.
Sources profile:This story draws on neutral-leaning sources
Idaho dairy cattle have tested positive for H5N1 in May 2026, ending a five-month gap in US dairy detections since Wisconsin in December 2025. CIDRAP assessed the detection as either renewed spread or persistent regional circulation in a zone where surveillance had gone quiet. The CDC human-case page has been frozen at 71 since 6 March, so the April-May human spillover count is unknown.
Moderna begins Phase 3 H5N1 mRNA trial
CEPI announced on 22 April that Moderna has begun the first Phase 3 trial of an mRNA-based H5N1 vaccine candidate, the furthest any mRNA H5N1 candidate has progressed.
Sources profile:This story draws on neutral-leaning sources
CEPI announced on 22 April that Moderna has begun the first Phase 3 trial of an mRNA H5N1 vaccine candidate, the furthest any H5N1 mRNA vaccine has progressed. Phase 3 collects efficacy and safety data at scale before a pandemic emerges, giving regulators a pre-built evidentiary record to draw on if they need to authorise rapidly.
Bangladesh and Cambodia keep the poultry H5N1 line
A child in Bangladesh died on 1 February after household poultry contact, and Cambodia has logged three H5N1 human cases in 2026, taking the global total outside the US dairy pathway to four.
Sources profile:This story draws on neutral-leaning sources
A child in Bangladesh died from H5N1 on 1 February 2026 after contact with household poultry. Cambodia recorded three separate human H5N1 cases in 2026. All four cases outside the US dairy pathway involved traditional poultry contact, not dairy cattle, making them a structurally different epidemic thread that has run in South and Southeast Asia for more than a decade.
Sources:CIDRAP
1 CIDRAP
Africa CDC and EU launch ARILAC for AMR
Africa CDC, ASLM and the EU launched ARILAC in Addis Ababa on 6 May, a four-year laboratory-capacity programme spanning eight African Union states on a One Health basis.
Sources profile:This story draws on neutral-leaning sources
Africa CDC, ASLM, and the EU launched ARILAC in Addis Ababa on 6 May, a four-year programme to build antimicrobial resistance testing capacity across eight African states. Only 1.3% of more than 50,000 assessed medical laboratories in 14 African countries currently run routine AMR tests, leaving 261 million people without any local resistance data.
Sources:Africa CDC
WHO publishes three Q1 pathogen-family roadmaps
The WHO R&D Blueprint published Filovirus, Arenaviridae and Paramyxovirus medical-countermeasure roadmaps in Q1 2026, with public consultations open through late May.
Sources profile:This story draws on neutral-leaning sources
WHO R&D Blueprint published three pathogen-family roadmaps in Q1 2026, covering filoviruses (Ebola, Marburg) on 3 March, Arenaviridae (Lassa, Junin) on 12 March, and paramyxoviruses (Nipah, Hendra) on 31 March. Public consultations remain open through late May. The Arenaviridae roadmap is directly relevant to Argentina, which carries both hantavirus and Junin virus.
Sources:World Health Organization
Closing comments
Hantavirus: the MV Hondius cluster is at the localised tier with confirmed Andes person-to-person capability; WHO's global risk assessment remains low, but ECDC's CDTR Week 19 response will determine whether the European secondary-monitoring footprint expands. H5N1: sustained mammal-to-mammal transmission in US dairy cattle continues, with clade 2.3.4.4b B3.13 now confirmed in milking-parlour aerosol and Idaho herds; the Emory aerosol finding is the specific mechanism that could push this from occupational to community exposure if CDC guidance remains calibrated to contact-only transmission. The tipping actor is CDC, and the dated trigger is whether PPE guidance is revised before the next milking season. PABS annex: a failed outcome at WHA79 in late May removes the operational backbone from the 2025 Pandemic Agreement without replacing it.
Different Perspectives
World Health Organization
WHO Disease Outbreak News 599, published 2 May, assessed the MV Hondius cluster as low global risk under standard hantavirus protocol. The Swiss Andes confirmation, released after DON 599 closed, makes that rodent-only framing outdated before the bulletin was indexed.
CEPI (Coalition for Epidemic Preparedness Innovations)
CEPI announced on 22 April that Moderna's mRNA H5N1 vaccine candidate entered Phase 3 trial. CEPI's position is that pre-pandemic efficacy data collected now is the only credible path to a 100 Days Mission authorisation if H5N1 achieves sustained human-to-human spread.
Africa CDC and ASLM
Africa CDC and ASLM launched ARILAC in Addis Ababa on 6 May alongside the EU, targeting AMR laboratory capacity in 8 AU states where 1.3% of assessed labs currently conduct routine resistance testing.
UK Health Security Agency
UKHSA confirmed on 6 May that British nationals are among MV Hondius cases and placed the UK in the European secondary-monitoring picture. UKHSA's active monitoring obligation covers Andes-specific person-to-person transmission risk, not generic hantavirus protocol.
NTI Bio and Resolve to Save Lives
NTI Bio and Resolve to Save Lives have consistently argued that the WHA Pandemic Agreement's Pathogen Access and Benefit-Sharing annex is its operational core. A failed PABS outcome at WHA79 in late May leaves the treaty without a legal mechanism for rapid vaccine sharing.